Twist Bioscience to Report Fiscal 2020 Third Quarter Financial Results on Thursday, August 6, 2020
July 30 2020 - 7:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that it will issue
its financial results for the fiscal 2020 third quarter ended June
30, 2020, following the close of market on Thursday, August 6,
2020. The company plans to hold a conference call and live audio
webcast for analysts and investors at 4:30 p.m. Eastern Time to
discuss its financial results and provide an update on the
company’s business. The press release with the financial results
will be accessible from the company’s website prior to the
conference call through the Investor Relations section under the
“Company” tab at www.twistbioscience.com.
The call can be accessed by dialing (866) 688-0947 (domestic) or
(409) 217-8781 (international) and refer to the conference ID
4462599. A telephonic replay of the conference call will be
available beginning approximately four hours after the call through
August 13, 2020 and may be accessed by dialing (855) 859-2056
(domestic) or (404) 537-3406 (international). The replay conference
ID is 4462599. The webcast replay will be available for two
weeks.
Given the circumstances globally, it is recommended to dial-in
at most 15 to 20 minutes prior to the call start to reduce waiting
times. If a participant will be listen-only, they are encouraged to
listen via the webcast on Twist’s investor page.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn |
YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200730005310/en/
Investor Contact: Argot Partners Maeve Conneighton 212-600-1902
maeve@argotpartners.com
Media Contact: Angela Bitting 925- 202-6211
media@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jul 2023 to Jul 2024